Perrigo study reveals post-lockdown anxieties of hay fever sufferers

Global self-care company Perrigo, and its hay fever relief brand, Beconase, has revealed that more than a third (37%) of those that suffer from hay fever admit to being concerned about socialising outside this spring and summer as COVID-19 restrictions ease.

The research, which surveyed 2,000 hay fever sufferers from across the UK, found that nearly half (47%) of hay fever sufferers worry that people around them will think they are contagious with a cold, the flu or Covid-19 while displaying hay fever symptoms.

While many people across Britain will be looking forward to meeting up with friends and family, the study, conducted via OnePoll, found that a third (34%) of sufferers actively avoid making plans to go outside when the pollen count is high.

Hay fever is a condition which affects 13 million people in the UK, and research suggests that prevalence is on the rise. The new study from Perrigo aimed to delve deeper into the issues hay fever sufferers experience, and better understand the toll the condition, and its symptoms, can take on sufferers.

Farah Ali, Superintendent Pharmacist at Warman-Freed, the learning pharmacy for Perrigo, said: “While many of us have embraced the opportunity to socialise outdoors recently, for hay fever sufferers these new freedoms can be hard to enjoy. Perrigo’s new data suggests that there is a sense amongst some sufferers that lockdown hasn’t ended, with many resigned to staying indoors when pollen counts soar. Community pharmacies can play a significant role in alleviating the impact of hay fever on people’s summer enjoyment, and supporting patients with advice and guidance on how to get hay fever symptoms under control.”

While most hay fever sufferers use medicines or treatments to prevent or relieve hay fever symptoms, a significant one in 10 don’t use any preventative treatments at all.

“We know that prevention is an important part of managing hay fever, and for a patient it could mean the difference between feeling able to enjoy socialising outside and feeling trapped indoors”, said Farah Ali. “Pharmacists, as self-care experts, are well placed to educate patients on the range of preventative treatments which are available to help stop the pollen before an allergic reaction has fully developed. Nasal defence sprays, such as Becodefence, can be particularly effective. By forming a barrier to pollen on the nasal lining they block contact with the allergen and quickly defuse it, helping to stop symptoms developing and getting worse.”

As a company, Perrigo is committed to supporting patients’ ability to self-care; to better understand their attitudes towards self-care and to empower them to better-manage minor ailments like hay fever through the use of its branded and retailer-branded products.